Acetylcholinesterase inhibition dose-response modeling for chlorpyrifos and chlorpyrifos-oxon

Regulatory Toxicology and Pharmacology

Volumn 63, Issue 1, 2012, Pages 124-131

  Reiss, Richard ^a   Neal, Barbara ^a   Lamb, James C ^a   Juberg, Daland R ^b  

^a EXPONENT INC   (United States)

^b DOW AGROSCIENCES LLC   (United States)

Author keywords

Acetylcholinesterase; Benchmark dose; Chlorpyrifos

Indexed keywords

ACETYLCHOLINESTERASE; ARACHIS OIL; CHLORPYRIFOS; CHLORPYRIFOS OXON; CORN OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXPERIMENTAL RAT; FEEDING; FEMALE; MALE; MILK; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; RISK ASSESSMENT; SEX DIFFERENCE; TOXICITY TESTING;

ACETYLCHOLINESTERASE; ADULT; ANIMALS; ANIMALS, NEWBORN; BRAIN; CHILD; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; RATS; RISK ASSESSMENT;

RATTUS; ZEA MAYS;

EID: 84859394600     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.03.008     Document Type: Article

References (28)

1. Akaike H. A new look at the statistical model identification. IEEE Trans. Automat. Contr. 1974, 19:716-723.
2. Beyene J., Moineddin R. Methods for confidence interval estimation of a ratio parameter with application to location quotients. BMC Med. Res. Methodol. 2005, 5:32.
3. Betancourt A.M., Carr R.L. The effect of chlorpyrifos and chlorpyrifos-oxon on brain cholinesterase, muscarinic receptor binding, and neurotrophin levels in rats following early postnatal exposure. Toxicol. Sci. 2004, 77:63-71.
4. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Introduction to Meta-analysis 2009, John Wiley & Sons, New York.
5. Brzak K.A., Harms D.W., Bartels M.J., Nolan R.J. Determination of chlorpyrifos, chlorpyrifos oxon, and 3,5,6-trichloro-2-pyridinol in rat and human blood. J. Anal. Toxicol. 1998, 22:203-210.
6. Carr R.L., Chambers H.W., Guarisco J.A., Richardson J.R., Tang J., Chambers J.E. Effects of repeated oral prenatal exposure to chlorpyrifos on open-field behavior in juvenile rats. Toxicol. Sci. 2001, 59:260-267.
7. Chambers J.E., Chambers H.W. Oxidative desulfation of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat brain and liver. J. Biochem. Toxicol. 1989, 4:201-203.
8. Fieller E.C. Some problems in interval estimation. J. Roy. Stat. Soc. B Met. 1954, 16:175-185.
9. Hoberman A.M. Developmental Neurotoxicity Study of Chlorpyrifos Administered Orally via Gavage to Crl:CD(R)BR VAF/Plus(R) Presumed Pregnant Rats 1998, Argus Research Laboratories, Inc., Horsham, Pennsylvania, (Laboratory Study No. 304-001).
10. Marable B.R., Maurissen J.P.J., Mattsson J.L., Billington R. Differential sensitivity of blood, peripheral, and central cholinesterases in beagle dogs following dietary exposure to chlorpyrifos. Regul. Toxicol. Pharmacol. 2007, 47:240-248.
11. Marty, M.S., Andrus, A.K., Bell, M.P., Passage, J.K., Perela, A.W., Brzak, K.A., Bartels, M.J., Beck, M.J., Juberg, D.R., 2012. Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos and chlorpyrifos-oxon. Submitted to Regul. Toxicol. Pharmacol.
12. Mattsson J.L., Maurissen J.P., Spencer P.J., Brzak K.A., Zablotny C.L. Effects of Chlorpyrifos Administered via Gavage to Cd Rats during Gestation and Lactation on Plasma, Erythrocyte, Heart and Brain Cholinesterase and Analytical Determination of Chlorpyrifos and Metabolites 1998, Health and Environmental Research Laboratories, The Dow Chemical Co. for Dow AgroSciences.
13. Mattsson J.L., Maurissen J.P., Nolan R.J., Brzak K.A. Lack of differential sensitivity to cholinesterase inhibition in fetuses and neonates compared to dams treated perinatally with chlorpyrifos. Toxicol. Sci. 2000, 53:438-446.
14. Maurissen J.P., Hoberman A.M., Garman R.H., Hanley T. Lack of selective developmental neurotoxicity in rat pups with dams treated by gavage with chlorpyrifos. Toxicol. Sci. 2000, 57:250-263.
15. Moser V.C., Simmons J.E., Gennings C. Neurotoxicological interactions of a five-pesticide mixture in preweanling rats. Toxicol. Sci. 2006, 92:235-245.
16. Munk O.L., Keiding S., Bass L. Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G671-G680.
17. Pope, C., 2001. Letter to the EPA FIFRA Science Advisory Panel. EPA Docket Control Number OPP-34203.
18. Richardson J.R., Chambers J.E. Neurochemical effects of repeated gestational exposure to chlorpyrifos in developing rats. Toxicol. Sci. 2004, 77:83-90.
19. Tang J., Carr R.L., Chambers J.E. Changes in rat brain cholinesterase activity and muscarinic receptor density during and after repeated oral exposure to chlorpyrifos in early postnatal development. Toxicol. Sci. 1999, 51:265-272.
20. Timchalk C., Poet T.S., Kousba A.A. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos. Toxicology 2006, 220:13-25.
21. US EPA. 2000. Office of Pesticide Programs Science Policy on the Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphorous and Carbamate Pesticides.
22. US EPA. 2002a. Implementation of Requirements Under FQPA. http://www.epa.gov/pesticides/regulating/laws/fqpa/fqpa_implementation.htm.
23. US EPA. 2002b. Revised OP cumulative risk assessment. http://www.epa.gov/oppsrrd1/cumulative/common_mech_groups.htm.
24. US EPA. 2006a. Organophosphate pesticides (OP) cumulative assessment - 2006 update. EPA-HQ-OPP-2006-0618. Available at US Environmental Protection Agency. http://www.epa.gov/oppsrrd1/cumulative/2006-op/index.htm.
25. US EPA. 2006b. Registration eligibility document (RED) for malathion. Document prepared by the Office of Pesticide Programs.
26. US EPA. 2008. Science issue paper: Chlorpyrifos Hazard And Dose-Response Characterization. Report to the FIFRA Scientific Advisory Panel, August, 2008.
27. Williams A.L., DeSesso J.M. The potential of selected brominated flame retardants to affect neurological development. J. Toxicol. Environ. Health B 2010, 13:411-448.
28. Zheng Q., Olivier K., Won Y.K., Pope C.N. Comparative cholinergic neurotoxicity or oral chlorpyrifos exposures in preweanling and adult rats. Toxicol. Sci. 2000, 55:124-132.